SGK AND NEDD USED AS DIAGNOSTIC AND THERAPEUTIC TARGETS

摘要

The invention relates to the use of a substance for the diagnostic detection of Sgk, especially Sgk1 and/or Sgk3, and/or PKB and/or Nedd, especially Nedd 4- 2, and to the use of active ingredients which influence glucose transport fo r treating diseases associated with disturbed glucose transport, and for fattening animals. The invention also relates to a diagnosis kit and a pharmaceutical composition comprising an active quantity of at least one active ingredient which influences glucose transport. The invention further relates to a method for producing transgenic animals.